Therapy Insulin Practical guide to Health Care Providers Quick Reference F Diabetes Mellitus in Type 2
|
|
- Rebecca Burns
- 8 years ago
- Views:
Transcription
1 Ministry of Health, Malaysia 2010 First published March 2011 Perkhidmatan Diabetes dan Endokrinologi Kementerian Kesihatan Malaysia Practical guide to Insulin Therapy in Type 2 Diabetes Mellitus Quick Reference For Health Care Providers
2 KEY MESSAGES 1. Pancreatic beta cell dysfunction begins many years prior to diagnosis of Type 2 diabetes 2. Following diagnosis, progressive insulin deficiency combined with insulin resistance results in worsening glycaemic control and failure of oral anti-diabetic therapy. 3. Insulin therapy should be initiated early when HbA1c is persistently above 8% despite optimal doses of oral anti-diabetic therapy. 4. The insulin regimen and insulin doses initiated should be indiviised, based on the patients blood glucose profile, lifestyle factors and patients preferences. 5. Metformin, an insulin sensitizer, should be continued at optimal doses following initiation of insulin therapy unless contraindications or intolerance exist. 6. Self monitoring of blood glucose along with simple patient-directed dose adjustments enable gra, safe and prompt insulin dose optimization. 7. Glycaemic targets need to be indiviised based on patients risk of hypoglycaemia, presence of complications and co-morbidities. 8. Insulin regimens may need to be changed or intensified with time if glycaemic targets are unmet despite dose optimization. 9. Minimizing both hypoglycemia and weight gain are important additional treatment targets for patients with Type 2 diabetes requiring insulin therapy. 10. Continuous patient education and support is a key element for optimal treatment adherence, patient empowerment and successful insulin therapy. SOURCES OF FUNDING The development of this quick reference guide was supported by an educational grant from sanofi-aventis TARGETS AND MONITORING Recommended timing of SMBG in different Insulin Regimens Breakfast Lunch Dinner Bedtime SMBG in basal/basal-bolus regimen Post Post Post Basal only Basal bolus (short-acting) Basal bolus (rapid-acting) SMBG in mixed Regimen -mixed Human BD -mixed Analogues BD -mixed Analogues TDS SMBG and Insulin Titratuion To Control Breakfast BG 2-hours Post-breakfast BG -lunch BG 2 hours Post-lunch BG -dinner BG Post-dinner/-bed BG Adjust -bed intermediate/long-acting insulin or pre-dinner premixed -breakfast rapid-acting or premixed insulin analogue. -breakfast short-acting or premixed insulin. -lunch rapid-acting or pre-breakfast premixed insulin. -lunch short-acting or pre-breakfast premixed insulin. -dinner rapid-acting or pre-dinner premixed insulin.
3 Intensification from mixed Regimen to Basal Bolus Regimen PREMIED INSULIN BD or TDS (Insulin analogue) FPG / premeals > 6 mmol/l HbA1c > 6.5 7% Switch to BOLUS REGIMEN Starting dose 0.5units/kg/day or total dose transfer Split dose 50:50 for basal and prandial insulin Divide prandial doses into 3 main meals Fix FPG < 6mmol/L using basal insulin Titrate bolus dose once / twice a week to achieve FPG and preprandial goal < 6mmol/L Stop SU, continue metformin Intensification from Prandial Regimen to Basal Bolus Regimen PRANDIAL TDS (Optimised prandial doses) FPG > 6 mmol/l HbA1c > 6.5 8% Addition of INSULIN BOLUS REGIMEN 10 units or 0.2U / kg at pre-dinner Monitor FPG, target 4-6 mmol/l Adjust basal insulin doses after 3 consecutive BG values obtained (every 3 7 days) - < 4 mmol/l ( > 1 value ) reduce dose by 2 units mmol/l ( all values ) maintain current dose - > 6 mmol/l ( >1 value, no hypos ) increase by 2 units Insulin preparations available in Malaysia and their pharmacokinetic profiles a) Short-acting, regular - Actrapid * - Humulin R * b) Rapid-acting analogue - Novorapid (Aspart)* - Humalog (Lispro)* - Apidra (Glulisine) c) Intermediate-acting, NPH - Insulatard * - Humulin N * d) Long-acting analogue - Glargine * - Detemir * e) mixed human (30% regular insulin+70% NPH) - Mixtard 30* - Humulin 30/70* f) mixed analogue - NovoMix 30 - Humalog Mix 25 Brand (Generic) Name Onset Peak (Hr) Duration (Hr) Timing of insulin * Available at Ministry of Health, Malaysia min 0-15 min 5-15 min 1.5 Hr 1 Hr 2-4 Hr 1 Hr min 0-15 min peakless peakless s before meal 5-15 mins before or immediately after meals -breakfast / -bed Same time everyday at anytime of the day mins before meals 5-15 mins before meals
4 Insulin regimens and frequency of injections per day No. of injections per day Insulin regimen PREMIED OD PREMIED BD -PLUS (1) -PLUS (2) PRANDIAL PREMIED TDS PREMIED-PLUS PREMIED-PLUS -BOLUS -BOLUS Type of insulin and timing Intermediate acting (NPH) insulin pre-bed Long-acting analogue once daily mixed/ premixed analogue pre-dinner Intermediate acting (NPH) pre-breakfast and pre-dinner mixed insulin pre-breakfast and pre-dinner Basal insulin once daily + 1 prandial insulin Basal insulin once daily + 2 prandial insulin Prandial insulin pre-breakfast, pre-lunch and pre-dinner mixed analogue pre-breakfast, pre-lunch and pre-dinner mixed insulin pre-breakfast, pre-dinner + 1 prandial insulin pre-lunch Prandial insulin pre-breakfast and pre-lunch + premixed insulin pre-dinner Basal insulin once daily + prandial insulin pre-breakfast, pre-lunch and pre-dinner Intermediate acting (NPH) insulin pre-breakfast and pre-dinner + prandial insulin pre-breakfast, pre-lunch and pre-dinner Insulin therapy 3 stage process INITIATION Starting insulin Strat requires selection of appropriate insulin regimen, insulin type and starting dose. OPTIMISATION Dose titration to ensure maximum benefit from prescribed treatment Dose should be adjusted every 3-7 days INTENSIFICATION Modification of an insulin regimen to acieve glycemic control Requires switching to more intensive regimens for better glycemic control Intensification of mixed Regimen to mix Plus PREMIED OD (pre-dinner) or BD PREMIED ONCE DAILY (pre-dinner) FPG 4-6 mmol/l, pre-lunch and pre-dinner > 6mmol/L Add PRANDIAL INSULIN (at morning and midday meal) PREMIED TWICE DAILY (pre-breakfast, pre-dinner) -dinner > 6 mmol/l Add PRANDIAL INSULIN (at midday meal) Add prandial insulin 6 units or 0.1unit/kg Titrate to next prandial BG target daily If subsequent pre-meal BG is - < 4 mmol/l ( > 1 value ) reduce dose by 2 units mmol/l ( all values ) maintain current dose - > 6 mmol/l ( >1 value, no hypos ) increase by 2 units
5 Intensification from mixed Regimen PREMIED OD PREMIED BD PREMIED BD PLUS PRELUNCH PRANDIAL PREMIED TDS (FOR ANALOGUES) BOLUS Intensification of mixed Regimen PREMIED OD (pre-dinner) or BD FPG and / or pre-dinner 4-6 mmol/l HbA1c > 6.5 8% FPG and / or pre-dinner > 6 mmol/l Titrate mix OD or BD to achieve FPG and / or predinner < 6mmol/L SWITCH TO PREMIED BD OR TDS (analogues only) DAILY (OD) TWICE DAILY (BD) Starting dose 0.3units/kg/day or total dose transfer Split the dose 50:50 pre-breakfast and pre-dinner Titrate insulin dose to achieve FPG and pre-dinner<6mmol/l TWICE DAILY (BD) THREE TIMES DAILY (TDS) Add 6 units or 10% total daily dose at lunch Titrate dose once or twice a week to next pre prandial goal < 6mmol/L Down titrate morning dose ( 2 4 units ) may be needed after adding lunch dose Continue metformin Consider premixed analogues if hypos Summary of treatment algorithm Newly diagnosed DM & Type 2 DM Symptomatic (osmotic symptoms) regardless HbA1c or FBS HbA1c > 10% or FPG > 13 mmol/l Type 2 DM on maximal OADs (single/double/triple) HbA1c > 8% Glycemic abnormality? FPG, SMBG Normal Fasting / prebreakfast BG High daytime BG High Fasting / prebreakfast BG Normal daytime BG High Fasting / prebreakfast BG High daytime BG INITIATE & OPTIMISE Start PRANDIAL only (usually TDS premeals) Start only (bedtime) Start PREMIED OD (predinner) Start PREMIED BD (prebreakfast & predinner) Start BOLUS (premeals, bedtime) INTENSIFY Add basal insulin Sequential addition of prandial insulin PLUS (premeal and bedtime) Add 3 prandial insulin PREMIED TDS* (premeals) Note: 1. Metformin should be continued while on insulin therapy unless contraindicated or intolerant 2. Sulphonylureas / Meglitinides should be withdrawn once prandial insulin is used regularly with meals 3. Insulin dose should be optimized prior to switching / intensifying regimens PREMIED BD PLUS PRANDIAL (prelunch) BOLUS (prandial insulin at premeals, basal insulin at bedtime) * refers to insulin analogues only
6 Insulin Regimen Starting Dose Dose Optimisation Optimal Dose Basal Insulin Initiation and Optimisation 10 units or 0.2U/kg at bedtime (0.1 units / kg if higher risk for hypos) Adjust insulin doses after 3 consecutive BG values obtained (every 3 7 days) Refer to (*) units/kg in lean patients units/kg in most patients Up to 0.7 units/kg in obese patients mixed Once daily: 10 units or 0.2U/kg at pre-dinner Twice daily: 10 units or 0.2U/ kg at pre-breakfast and predinner (0.1units/kg if higher risk for hypos) Adjust insulin doses after 3 consecutive BG values obtained (every 3 7 days) Refer to (*) -breakfast BG determine pre-dinner premixed dose adjustment -dinner BG determine pre-breakfast premixed dose adjustment Total daily dose of units/kg in most patients (Maybe more than 1.0 units/kg/day in obese, insulin resistant patients) Prandial 6 units or 0.1units/kg for each meal with short-acting or rapid-acting analogue. Adjust insulin doses after 3 consecutive BG values obtained (every 3 7 days) Refer to (*) Adjust the dose of prandial insulin of the preceding meal (eg: if pre lunch BG is high, adjust pre-breakfast prandial insulin) Prandial dose for each meal will vary according to carbohydrate content and amount. Dose should ideally not exceed 0.5U/kg/dose. Basal Bolus Prandial Insulin: 6 units or 0.1U/kg before each meal Basal insulin: 10 units or 0.2U/kg at bedtime Refer to Prandial Section Refer to Basal Section Aim for normal pre-breakfast BG first by adjusting the dose of bed-time basal insulin before adjusting the prandial (bolus) insulin dose. (*) - < 4 mmol/l (> 1 value) reduce dose by 2 units mmol/l (all values) maintain current dose - > 6 mmol/l (>1 value, no hypos) increase by 2 units Generally basal insulin would contribute 50% of total daily insulin dose and prandial insulin would contribute remaining 50% (distributed over three main meals). Refer to Prandial Section & Basal Section Insulin Intensification Intensification from Basal Regimen PREMIED BD BOLUS PLUS (1 / 2 / 3 PRANDIAL) Note: Optimise Basal Before Intensification Fix Fasting Blood Glucose (FBG) first using basal insulin (dose optimisation) Goal FBG 4 6 mmol/l Consider adding bolus / meal insulin when: Hb A1c > 7% and FBG at goal or basal insulin dose > 0.5U/kg Intensification from Basal to mixed Regime Intensification from Basal to Basal Bolus regimen Intensification from Basal to Basal Plus regimen Switch to PREMIED TWICE DAILY Total dose transfer Split dose 50:50 pre-breakfast : pre-dinner Titrate dose once / twice a week to next preprandial goal Stop SU, continue metformin Consider premixed analogue Add prandial insulin 6 units or 0.1unit/kg at each meal Monitor BG up to 4 times per day Titrate to next pre-meal / bedtime BG target daily If subsequent pre-meals BG are Refer to (*) Stop SU and continue metformin If HbA1c > 6.5-7% after 3 months despite titrating prandial doses or prandial doses > 30 units per meal, consider: Resume optimisation of basal insulin up to 0.7 U/kg Perform 7- point BG profile Add initial dose of prandial 6 units or 0.1unit/kg at largest meal Titrate to next pre-meal / bedtime BG target daily If subsequent premeals BG are Refer to (*) Discontinue SU on addition of prandial insulin Continue metformin Patients may need to perform SMBG up to 4 times per day If HbA1c > 6.5-7% after 3 months despite titrating doses, or prandial doses > 30U per meal, consider: Add 2 nd dose of prandial insulin at 6 units or 0.1unit/kg at 2 nd largest meal and titrate as before Subsequently may add 3 rd dose of prandial insulin if required (*) - < 4 mmol/l (> 1 value) reduce dose by 2 units mmol/l (all values) maintain current dose - > 6 mmol/l (>1 value, no hypos) increase by 2 units
TYPE 2 DIABETES SEQUENTIAL INSULIN STRATEGIES
TYPE 2 DIABETES SEQUENTIAL INSULIN STRATEGIES Non-insulin regimes Basal insulin only (usually with oral agents) Number of injections 1 Regimen complexity Low Basal insulin +1 meal-time rapidacting insulin
More informationAlgorithms for Glycemic Management of Type 2 Diabetes
KENTUCKY DIABETES NETWORK, INC. Algorithms for Glycemic Management of Type 2 Diabetes The Diabetes Care Algorithms for Type 2 Diabetes included within this document are taken from the American Association
More informationINSULIN TREATMENT FOR TYPE 2 DIABETES MANAGEMENT
INSULIN TREATMENT FOR TYPE 2 DIABETES MANAGEMENT APIRADEE SRIWIJITKAMOL DIVISION OF ENDOCRINOLOGY AND METABOLISM DEPARTMENT OF MEDICINE FACULTY OF MEDICINE SIRIRAJ HOSPITOL QUESTION 1 1. ท านเคยเป นแพทย
More informationWorkshop A Tara Kadis
Workshop A Tara Kadis Considerations/barriers in decision making about insulin verses GLP-1 use in people with type 2 diabetes Which Insulin regimes should we consider? Diabetes is a progressive multi-system
More informationThe basal plus strategy. Denis Raccah, MD, PhD Professor of Medicine University Hospital Sainte Marguerite Marseille FRANCE
The basal plus strategy Denis Raccah, MD, PhD Professor of Medicine University Hospital Sainte Marguerite Marseille FRANCE ADA/EASD guidelines recommend use of basal insulin as early as the second step
More informationFOREWORD PREFACE GUIDE OBJECTIVES GUIDE WORKING COMMITTEE EXTERNAL REVIEWERS SUMMARY OF TREATMENT ALGORITHM
TABLE OF CONTENTS FOREWORD PREFACE GUIDE OBJECTIVES GUIDE WORKING COMMITTEE EXTERNAL REVIEWERS SUMMARY OF TREATMENT ALGORITHM i ii iii iv v vi SECTION 1 BACKGROUND 1 SECTION 2 RATIONALE FOR INSULIN THERAPY
More informationInsulin Initiation and Intensification
Insulin Initiation and Intensification ANDREW S. RHINEHART, MD, FACP, CDE MEDICAL DIRECTOR AND DIABETOLOGIST JOHNSTON MEMORIAL DIABETES CARE CENTER Objectives Understand the pharmacodynamics and pharmacokinetics
More informationA Simplified Approach to Initiating Insulin. 4. Not meeting glycemic goals with oral hypoglycemic agents or
A Simplified Approach to Initiating Insulin When to Start Insulin: 1. Fasting plasma glucose (FPG) levels >250 mg/dl or 2. Glycated hemoglobin (A1C) >10% or 3. Random plasma glucose consistently >300 mg/dl
More informationA new insulin order form should be completed for subsequent changes to type of insulin and/or frequency of administration
of nurse A new insulin order form should be completed for subsequent changes to type of insulin and/or frequency of administration 1. Check times for point of care meter blood glucose testing. Pre-Breakfast
More informationIntensive Insulin Therapy in Diabetes Management
Intensive Insulin Therapy in Diabetes Management Lillian F. Lien, MD Medical Director, Duke Inpatient Diabetes Management Assistant Professor of Medicine Division of Endocrinology, Metabolism, & Nutrition
More informationINSULIN INTENSIFICATION: Taking Care to the Next Level
INSULIN INTENSIFICATION: Taking Care to the Next Level By J. Robin Conway M.D., Diabetes Clinic, Smiths Falls, ON www.diabetesclinic.ca Type 2 Diabetes is an increasing problem in our society, due largely
More informationIntensifying Insulin Therapy
Intensifying Insulin Therapy Rick Hess, PharmD, CDE, BC-ADM Associate Professor Gatton College of Pharmacy, Department of Pharmacy Practice East Tennessee State University Johnson City, Tennessee Learning
More informationGlycaemic Control in Adults with Type 1 Diabetes
Glycaemic Control in Adults with Type 1 Diabetes Aim(s) and objective(s) This document aims to provide guidance on good clinical practice in managing glycaemic control in adult patients with Type 1 Diabetes
More informationDiabetes: When To Treat With Insulin and Treatment Goals
Diabetes: When To Treat With Insulin and Treatment Goals Lanita. S. White, Pharm.D. Director, UAMS 12 th Street Health and Wellness Center Assistant Professor of Pharmacy Practice, UAMS College of Pharmacy
More informationINPATIENT DIABETES MANAGEMENT Robert J. Rushakoff, MD Professor of Medicine Director, Inpatient Diabetes University of California, San Francisco
INPATIENT DIABETES MANAGEMENT Robert J. Rushakoff, MD Professor of Medicine Director, Inpatient Diabetes University of California, San Francisco CLINICAL RECOGNITION Background: Appropriate inpatient glycemic
More informationInsulin switch & Algorithms Rotorua GP CME June 2011. Kingsley Nirmalaraj FRACP Endocrinologist BOPDHB
Insulin switch & Algorithms Rotorua GP CME June 2011 Kingsley Nirmalaraj FRACP Endocrinologist BOPDHB Goal of workshop Insulin switching make the necessary move Ensure participants are confident with Recognising
More informationInitiation and Adjustment of Insulin Regimens for Type 2 Diabetes
PL Detail-Document #300128 This Detail-Document accompanies the related article published in PHARMACIST S LETTER / PRESCRIBER S LETTER January 2014 Initiation and Adjustment of Insulin Regimens for Type
More informationInsulin Therapy. Endocrinologist. H. Delshad M.D. Research Institute For Endocrine Sciences
Insulin Therapy H. Delshad M.D Endocrinologist Research Institute For Endocrine Sciences Primary Objectives of Effective Management A1C % 9 8 Diagnosis SBP mm Hg LDL mg/dl 7 145 130 140 100 Reduction of
More informationInsulin: Breaking Barriers Enhancing Therapies. Jerry Meece, RPh, FACA, CDE jmeece12@cooke.net
Insulin: Breaking Barriers Enhancing Therapies Jerry Meece, RPh, FACA, CDE jmeece12@cooke.net Questions To Address Who are candidates for insulin? When do we start insulin? How do the different types of
More informationInsulin onset, peak and duration of action
Insulin onset, peak and duration of action Insulin was first discovered in the early 190 s. Before then, diabetes could not be treated. Insulin was then taken from cow and pig pancreases, but nearly all
More informationEveryday Practice: Diabetes Mellitus
THE NATIONAL MEDICAL JOURNAL OF INDIA VOL. 20, NO. 5, 2007 245 Everyday Practice: Diabetes Mellitus Insulin therapy for patients with type 2 diabetes mellitus NISHA R. S., E. BHATIA INTRODUCTION India
More informationDiabetes Management Tube Feeding/Parenteral Nutrition Order Set (Adult)
Review Due Date: 2016 May PATIENT CARE ORDERS Weight (kg) Known Adverse Reactions or Intolerances DRUG No Yes (list) FOOD No Yes (list) LATEX No Yes ***See Suggestions for Management (on reverse)*** ***If
More informationWhen and how to start insulin: strategies for success in type 2 diabetes
1 When and how to start insulin: strategies for success in type diabetes Treatment of type diabetes in 199: with each step treatment gets more complex Bruce H.R. Wolffenbuttel, MD PhD Professor of Endocrinology
More informationInitiating & titrating insulin & switching in General Practice Workshop 1
Initiating & titrating insulin & switching in General Practice Workshop 1 Workshop goal To make participants comfortable in the timely initiation and titration of insulin Progression of Type 2 Diabetes
More informationInsulin Therapy In Type 2 DM. Sources of support. Agenda. Michael Fischer, M.D., M.S. The underuse of insulin Insulin definition and types
Insulin Therapy In Type 2 DM Michael Fischer, M.D., M.S. Sources of support NaRCAD is supported by a grant from the Agency for Healthcare Research and Quality My current research projects are funded by
More informationADJUSTING INSULIN DOSES CONFLICTS OF INTEREST
ADJUSTING INSULIN DOSES CONFLICTS OF INTEREST Vahid Mahabadi, MD Research grants from Sanofi and Amylin Pharmaceutical Companies Mayer B. Davidson, MD Advisory Board Sanofi Pharmaceutical Company Chief
More informationUser guide Basal-bolus Insulin Dosing Chart: Adult
Contacts and further information Local contact Clinical pharmacy or visiting pharmacy Diabetes education service Director of Medical Services Visiting or local endocrinologist or diabetes physician For
More informationTYPE2DIABETES INSULIN TREATMENT 2009 UPDATE ON A HEALTHCARE PROFESSIONAL S GUIDE TO TREATMENT BY J. ROBIN CONWAY, MD. www.diabetesclinic.
TYPE2DIABETES INSULIN TREATMENT 2009 UPDATE ON A HEALTHCARE PROFESSIONAL S GUIDE TO TREATMENT BY J. ROBIN CONWAY, MD www.diabetesclinic.ca Author: Dr. Robin Conway Note to readers The contents herein represent
More information10 to 30 minutes ½ to 3 hours 3 to 5 hours. 30 60 minutes 1 to 5 hours 8 hours. 1 to 4 hours
Insulin Action There are several types of insulin. They are classified by how long they act: very fast, fast, slow and very slow acting. Each type of insulin has a certain time period in which it works.
More informationDIABETES - INSULIN INITIATION - BACKGROUND INFORMATION (1)
DIABETES - INSULIN INITIATION - BACKGROUND INFORMATION (1) KEY PRINCIPLES Many patients with Type 2 diabetes will require insulin therapy. In the UKPDS over 50% of patients by 6 years required additional
More informationCLASS OBJECTIVES. Describe the history of insulin discovery List types of insulin Define indications and dosages Review case studies
Insulins CLASS OBJECTIVES Describe the history of insulin discovery List types of insulin Define indications and dosages Review case studies INVENTION OF INSULIN 1921 The first stills used to make insulin
More informationPresented By: Dr. Nadira Husein
Presented By: Dr. Nadira Husein I have no conflict of interest Disclosures I have received honoraria/educational grants from the following: Novo Nordisk, Eli Lilly, sanofi-aventis, Novartis, Astra Zeneca,
More informationMany patients with type 2 diabetes will ultimately need
SUPPLEMENT TO JAPI april 2011 VOL. 59 17 Insulin Initiation and Intensification: Insights from New Studies Ajay Kumar 1, Sanjay Kalra 2 Abstract Tight glycemic control is central to reducing the risk of
More informationMost patients with T2DM will eventually require insulin therapy. ADA Glycemic Control Targets. What are some of the obstacles?
ADA Glycemic Control Targets A1C < 7% Preprandial plasma glucose 70-130 mg/dl Postprandial plasma glucose (PPG)
More informationLeicestershire Diabetes Guidelines: Insulin Therapy
Endorsed by Leicestershire Medicines Strategy Group Leicestershire Diabetes Guidelines: Insulin Therapy These guidelines are designed for use by those trained and competent in insulin initiation and management
More informationINSULIN AND INCRETIN THERAPIES: WHAT COMBINATIONS ARE RIGHT FOR YOUR PATIENT?
INSULIN AND INCRETIN THERAPIES: WHAT COMBINATIONS ARE RIGHT FOR YOUR PATIENT? MARTHA M. BRINSKO, MSN, ANP-BC CHARLOTTE COMMUNITY HEALTH CLINIC CHARLOTTE, NC Diagnosed and undiagnosed diabetes in the United
More informationINSULIN REGIMENS in type 2 diabetes
A review of INSULIN and INSULIN REGIMENS in type 2 diabetes a Joshi P, PhD, FRCP,FRS Med, FICA Joshi S, MBChB, MSc(Pharm) Med(UL) Diabetes Care Centre, Louis Pasteur Medical Centre, Pretoria a Emeritus
More informationDiabetes and the Elimination of Sliding Scale Insulin. Date: April 30 th 2013. Presenter: Derek Sanders, D.Ph.
Diabetes and the Elimination of Sliding Scale Insulin Date: April 30 th 2013 Presenter: Derek Sanders, D.Ph. Background Information Epidemiology and Risk Factors Diabetes Its Definition and Its Impact
More informationInsulin/Diabetes Calculations
Insulin/Diabetes Calculations Dr. Aipoalani St Lukes Endocrinology Goals Describe various calculations for insulin dosing Understand importance of the total daily dose (TDD) of insulin Be able to calculate
More informationINSULIN INITIATION IN TYPE 2 DIABETES IN PRIMARY CARE
INSULIN INITIATION IN TYPE 2 DIABETES IN PRIMARY CARE We welcome feedback on this policy and the way it operates. We are interested to know of any possible or actual adverse impact that this policy/procedure
More informationLead Clinician(S) (DATE) Approved by Diabetes Directorate on: Approved by Medicines Safety Group on: This guideline should not be used after end of:
Guideline for members of the diabetes team and dietetic department for advising on insulin dose adjustment and teaching the skills of insulin dose adjustment to adults with type 1 or type 2 diabetes mellitus
More informationPrior Authorization Guideline
Prior Authorization Guideline Guideline: PC - Apidra, Levemir Therapeutic Class: Hormones and Synthetic Substitutes Therapeutic Sub-Class: Antidiabetic Agents Client: CA, CO, NV, OK, OR, WA and AZ Approval
More informationDiabetes Medications: Insulin Therapy
Diabetes Medications: Insulin Therapy Courtesy Univ Texas San Antonio Eric L. Johnson, M.D. Department of Family and Community Medicine Diabetes and Insulin Type 1 Diabetes Autoimmune destruction of beta
More informationGlycemic Control Initiative: Insulin Order Set Changes Hypoglycemia Nursing Protocol
Glycemic Control Initiative: Insulin Order Set Changes Hypoglycemia Nursing Protocol Ruth LaCasse Kalish, RPh Department of Pharmacy Objectives Review the current practice at UConn Health with sliding
More informationGuideline for Insulin Therapeutic Review in patients with Type 2 Diabetes
Diabetes Sans Frontières Guideline for Insulin Therapeutic Review in patients with Type 2 Diabetes 1. Introduction This guideline has been developed in order to support practices to undertake insulin therapeutic
More informationType 2 Diabetes: When to Initiate And Intensify Insulin Therapy. Julie Bate on behalf of: Dr John Wilson Endocrinologist Capital and Coast DHB
Type 2 Diabetes: When to Initiate And Intensify Insulin Therapy Julie Bate on behalf of: Dr John Wilson Endocrinologist Capital and Coast DHB Declarations I have received travel funding and speaker fees
More informationCalculating Insulin Dose
Calculating Insulin Dose First, some basic things to know about insulin: Approximately 40-50% of the total daily insulin dose is to replace insulin overnight, when you are fasting and between meals. This
More informationInsulin Algorithm for Type 2 Diabetes Mellitus in Children and Adults
Insulin Algorithm for Type 2 Diabetes Mellitus in Children and Adults Stock # 45-11647 Revised 10/28/10 Glycemic Goals 1,2 Individualize goal based on patient risk factors A1c 6%
More informationClinical Guideline Diabetes management during surgery (adults)
Clinical Guideline Diabetes management during surgery (adults) Standard 8 of the National Service Framework for Diabetes states that all children, young people and adults with diabetes admitted to hospital,
More informationIntensifying Insulin In Type 2 Diabetes
Intensifying Insulin In Type 2 Diabetes Eric L. Johnson, M.D. Associate Professor Department of Family and Community Medicine University of North Dakota School of Medicine and Health Sciences Assistant
More informationINSULIN ALGORITHM FOR TYPE 2 DIABETES MELLITUS IN CHILDREN 1 AND ADULTS
Publication # 45-11647 Targets*
More informationInsulin therapy in various type 1 diabetes patients workshop
Insulin therapy in various type 1 diabetes patients workshop Bruce H.R. Wolffenbuttel, MD PhD Dept of Endocrinology, UMC Groningen website: www.umcg.net & www.gmed.nl Twitter: @bhrw Case no. 1 Male of
More informationSurgery and Procedures in Patients with Diabetes
Surgery and Procedures in Patients with Diabetes University Hospitals of Leicester NHS Trust DEFINITIONS Minor Surgery and Procedures: expected to be awake, eating and drinking by the next meal, total
More informationInsulin pen start checklist
Insulin pen start checklist Topic Instruction Date & Initials 1. Cognitive Assessment 2. Insulin Delivery loading appropriate mixing priming shot dialing up dose delivery of insulin 3. Insulin type/action
More information(30251) Insulin SQ Prandial Carbohydrate
Diagnosis Patient MUST BE educated using carbohydrate counting for prial insulin coverage before hospitalization to be eligible for this order set Nursing Metered Glucose (Single Select Section) Metered
More informationHow to adjust your insulin if taken two or three times daily. To change the insulin dose, you will need to know:
What to do if your results are too high or too low The target range for your blood glucose results is from to 8 mmol/l - aim to have four out of every five blood glucose results in this range. If three
More informationInsulin Dose Adjustment REAL-Time CGMS Guidelines for Subjects on Pump Therapy
Insulin Dose Adjustment REAL-Time CGMS Guidelines for Subjects on Pump Therapy In addition to using the blood sugar logs to adjust your insulin doses every week, you should also use your continuous glucose
More informationInsulin use in Type 2 Diabetes. Dr Rick Cutfield. Why? When? How?
Insulin use in Type 2 Diabetes Dr Rick Cutfield Why? When? How? 1 Conflict of Interest I have been on advisory boards or had speaker fees from the following pharmaceutical companies: - Eli Lilly - Novo
More informationThe first injection of insulin was given on
EFFECTIVE USE OF INSULIN THERAPY IN TYPE 2 DIABETES * Bernard Zinman, MDCM ABSTRACT Type 2 diabetes is a progressive disease; an individual s ability to secrete insulin in increasing amounts to overcome
More informationINSULINThere are. T y p e 1 T y p e 2. many different insulins for
T y p e 1 T y p e 2 INSULINThere are many different insulins for Characteristics The three characteristics of insulin are: Onset. The length of time before insulin reaches the bloodstream and begins lowering
More informationYour Insulin Adjustment Workbook Yes, You Can Do It!
S T AY I N G O N T A R G E T TARGET THERAPY Staying on Target TM Your Insulin Adjustment Workbook Yes, You Can Do It! YES, YOU CAN DO IT! Your How-To Guide for Adjusting Basal and Bolus Insulin This workbook
More informationTYPE 2 DIABETES CRITERIA FOR REFERRAL TO LEVEL 2 OOHS
TYPE 2 DIABETES CRITERIA FOR REFERRAL TO LEVEL 2 OOHS The aim of the Diabetes level 2 service is to provide a high quality service for safe initiation and optimization of injectable therapy within GP networks.
More informationType 2 diabetes mellitus
Type 2 diabetes mellitus CLINICAL PRACTICE Management Guidelines for initiating insulin therapy BACKGROUND Insulin is often indicated for patients with suboptimally controlled type 2 diabetes mellitus,
More informationINSULIN FOR GESTATIONAL and PREGESTATIONAL DIABETES
INSULIN FOR GESTATIONAL and PREGESTATIONAL DIABETES There have been several changes in the management of diabetes during pregnancy, including the use of insulin analogs. The Sweet Success Guidelines, revised
More informationThere seem to be inconsistencies regarding diabetic management in
Society of Ambulatory Anesthesia (SAMBA) Consensus Statement on Perioperative Blood Glucose Management in Diabetic Patients Undergoing Ambulatory Surgery Review of the consensus statement and additional
More informationScottish Medicines Consortium
Scottish Medicines Consortium insulin glulisine for subcutaneous injection 100 units/ml (Apidra ) No. (298/06) Sanofi Aventis 4 August 2006 The Scottish Medicines Consortium (SMC) has completed its assessment
More informationNCT00272090. sanofi-aventis HOE901_3507. insulin glargine
These results are supplied for informational purposes only. Prescribing decisions should be made based on the approved package insert in the country of prescription Sponsor/company: Generic drug name:
More informationResident s Guide to Inpatient Diabetes
Resident s Guide to Inpatient Diabetes 1. All patients with diabetes of ANY TYPE, regardless of reason for admission, must have a Hemoglobin A1C documented in the medical record within 24 hours of admission
More informationType 2 Diabetes Adult Outpatient Insulin Guidelines Sutter Medical Foundation. February 2011.
Type 2 Diabetes Adult Outpatient Insulin Guidelines. GENERAL RECOMMENDATIONS Start insulin if A1C and glucose levels are above goal despite optimal use of other diabetes medications. (Consider insulin
More informationMANAGEMENT OF TYPE - 1 DIABETES MELLITUS
MANAGEMENT OF TYPE - 1 DIABETES MELLITUS INVESTIGATIONS AND TREATMENT MANSI NAIK VII SEMESTER INVESTIGATIONS FASTING BLOOD SUGAR PLASMA GLUCOSE HEMOGLOBIN A 1c SYMPTOMS OF TYPE 1 DIABETES MELLITUS Polyuria
More informationInformation for Patients
Information for Patients Guidance for Diabetic Persons having bowel preparation for a flexible sigmoidoscopy or a colonoscopy or a combined gastroscopy and colonoscopy This guidance is provided to assist
More informationInsulin Treatment. J A O Hare. www.3bv.org. Bones, Brains & Blood Vessels
Insulin Treatment J A O Hare www.3bv.org Bones, Brains & Blood Vessels Indications for Insulin Treatment Diabetic Ketoacidosis Diabetics with unstable acute illness ICU Gestational Diabetes: diet failure
More informationDesigner Insulins. History case 1. Follow up - case 1. Follow up - case 1. History - case 2. 24 hr glucose profile - case 1
History case 1 33 yr old male bank manager Designer Insulins Dr A Qureshi MB ChB (Edin), MD (Lon), CCT (Lon), FRCP (Lon) Consultant in Endocrinology, Diabetes and General Internal Medicine w w w. e n d
More informationKaiser Sunnyside Medical Center Inpatient Pharmacy Manual
Page: 1 of 10 PURPOSE To provide a standard procedure for optimizing care of the inpatient with hyperglycemia and/or diabetes. Substantially provide safe and effective glucose control for all adult inpatients.
More informationMedical Policy An independent licensee of the Blue Cross Blue Shield Association
Afrezza Page 1 of 6 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: Afrezza (human insulin) Prime Therapeutics will review Prior Authorization requests Prior Authorization
More informationTypes of insulin and How to Use Them
Diabetes and Insulin Pumps Amy S. Pullen Pharm.D ISHP Spring Meeting April 2012 Objectives Describe the different types of insulin used in diabetes Identify the types of insulin that are compatible with
More informationLipodystrophy: Metabolic and Clinical Aspects. Resource Room Slide Series
Lipodystrophy: Metabolic and Clinical Aspects Resource Room Slide Series Current Thinking About the Diagnosis and Treatment of the Insulin-Resistant State: How to Use Insulin Therapy Irl B. Hirsch, MD
More informationDiabetes Mellitus 1. Chapter 43. Diabetes Mellitus, Self-Assessment Questions
Diabetes Mellitus 1 Chapter 43. Diabetes Mellitus, Self-Assessment Questions 1. A 46-year-old man presents for his annual physical. He states that he has been going to the bathroom more frequently than
More informationSteroid Therapy and Management of Hyperglycaemia
Steroid Therapy and Management of Hyperglycaemia Table of Contents Rationale...1 Scope of guidelines...2 Outcome statement...2 Aims of management...2 Effects of glucocorticoids...2 Types of steroids commonly
More informationInsulin. Regimens Characteristics / categorization Pharmacokinetics / pharmacodynamics Adverse effects Compatibility Costs
Insulin Regimens Characteristics / categorization Pharmacokinetics / pharmacodynamics Adverse effects Compatibility Costs Insulins Rapid-acting Inhaled Short-acting Basal/ Intermediate Basal Pre-mixed
More informationInsulin therapy in type 2 diabetes When and how? Disclosures. Learning Objectives. None relevant to today s talk
Insulin therapy in type 2 diabetes When and how? Cecilia C Low Wang, MD Univ Colorado AMC SOM Department of Medicine Division of Endocrinology, Metabolism, and Diabetes Disclosures None relevant to today
More informationeducation Insulin delivery devices Paper Current insulin preparations Discovery of insulin and key developments in preparations
Paper 2009 Royal College of Physicians of Edinburgh Insulin delivery devices 1 AJ Graveling, 2 EA McIntyre 1 Specialty Registrar; 2 Consultant, Department of Diabetes & Endocrinology, Monklands Hospital,
More informationPrinciples on Insulin Treatments. Insulin & Type 2 Diabetes. Natural History of Type 2 Diabetes. Why Consider Insulin Early?
Principles on Treatments & Type 2 Diabetes Jessica Castle, MD Assistant Professor, OHSU Harold Schnitzer Diabetes Health Center Natural History of Type 2 Diabetes Severity of Diabetes UKPDS: Over Time,
More informationInsulin: A Practice Update. Department of Nursing Staff Development Elizabeth Borgelt, MS, RN
Insulin: A Practice Update Department of Nursing Staff Development Elizabeth Borgelt, MS, RN Learning Outcome The learner will be able to identify the different types of insulins available, their actions,
More informationInsulin therapy in type 2 diabetes
Med Clin N Am 88 (2004) 865 895 Insulin therapy in type 2 diabetes Trent Davis, MD, Steven V. Edelman, MD* Section of Diabetes/Metabolism, Veterans Affairs San Diego HealthCare System, 3350 La Jolla Village
More informationHEALTH SERVICES POLICY & PROCEDURE MANUAL
Page 1 of 5 PURPOSE To assure that DOP inmates with Diabetes, who require insulin therapy, are receiving high quality Primary Care for their condition. POLICY All DOP Primary Care Providers are to follow
More informationDonovan Victorine Pharm.D. BCACP Clinical Pharmacy Specialist Boise VA Medical Center. U-500 Insulin
Donovan Victorine Pharm.D. BCACP Clinical Pharmacy Specialist Boise VA Medical Center U-500 Insulin Understand differences between U-500 concentrated insulin and standard insulin formulations Recognize
More informationChapter 2 Subcutaneous Insulin: A Guide for Dosing Regimens in the Hospital
Chapter 2 Subcutaneous Insulin: A Guide for Dosing Regimens in the Hospital Karen Barnard, Bryan C. Batch, and Lillian F. Lien Keywords Basal-bolus insulin Prandial insulin Basal insulin Correction dose
More informationInsulin T Y P E 1 T Y P E 2
T Y P E 1 T Y P E 2 INSULIN There are many different insulins for many different situations and lifestyles. This section should help you and your doctor decide which insulin or insulins are best for you.
More informationInsulin and Diabetes
Insulin What is Insulin? Insulin is a hormone produced by special cells in the pancreas These cells that are produced are called beta cells Insulin allows the glucose from food we eat to enter the cells
More informationInsulin Therapy for Optimizing Glycemic Control in Type 2 DM. Puntip Tantiwong Department of Medicine Maharat Nakhon Ratchasima Hospital 22 May 2013
Insulin Therapy for Optimizing Glycemic Control in Type 2 DM Puntip Tantiwong Department of Medicine Maharat Nakhon Ratchasima Hospital 22 May 2013 Case 1 A 45 years-old Thai female with T2DM for 3 years
More informationDIABETES CARE PROGRAM OF NOVA SCOTIA INSULIN DOSE ADJUSTMENT POLICIES & GUIDELINES MANUAL, 2012
DIABETES CARE PROGRAM OF NOVA SCOTIA INSULIN DOSE ADJUSTMENT POLICIES & GUIDELINES MANUAL, 2012 Published by: Diabetes Care Program of Nova Scotia 1276 South Park Street, Bethune Building, Room 548 Halifax,
More informationSUBJECT: DIABETES MEDICATION MANAGEMENT PROTOCOLS
SUBJECT: DIABETES MEDICATION MANAGEMENT PROTOCOLS PURPOSE To establish a process that will enable Certified Diabetes Educators (CDE) and/or staff with Board Certification in Advanced Diabetes Management
More informationPresent and Future of Insulin Therapy: Research Rationale for New Insulins
Present and Future of Insulin Therapy: Research Rationale for New Insulins Current insulin analogues represent an important advance over human insulins, but clinically important limitations of these agents
More informationCase Studies: Initiation and Optimization of Insulin Therapy. Martha Nolte Kennedy, MD UCSF March, 2009
Case Studies: Initiation and Optimization of Insulin Therapy Martha Nolte Kennedy, MD UCSF March, 2009 When to Start Insulin? Insulinopenia: DM1, LADA, DM2 failed other medications, s/p Pancreatectomy,
More informationChapter 8 Insulin: Types and Activit y
Chapter 8 Insulin: Types and Activit y H. Peter Chase, MD Satish Garg, MD INSULIN Before insulin was discovered in 1921, there was little help for people who had type 1 diabetes. Since then, millions of
More informationCochrane Quality and Productivity topics
Long-acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitus NICE has developed the Cochrane Quality and Productivity (QP) topics to help the NHS identify practices
More informationThe Early Use of Insulin and Oral Anti diabetic Drugs
The Early Use of Insulin and Oral Anti diabetic Drugs NPS Outreach Pharmacists for Remote Aboriginal Health Services Strategy A remote perspective Dr Hugh Heggie National Medicine Policy To provide timely
More informationThe prevalence of type 2 diabetes
Insulin Therapy for Management of Type 2 Diabetes Mellitus: Strategies for Initiation and Long-term Patient Adherence Steven H. Barag, DO Effective glycemic control is essential to minimize the long-term
More informationDesktop Guidelines for Insulin Adjustment
Desktop Guidelines for Insulin Adjustment Disclaimer and terms of use: This document and workshop (the Material ) has been prepared for informational and training purposes for employees of the Endocrinology
More information